Congress Begins Shaping A Research Bonanza

Question of the day: Why is basic research, particularly biomedical research, like highways and bridges? Answer: Because Congress loves them both, especially in this election year. 'MIRACULOUS': NIH, under the direction of Harold Varmus, would get an 8.4 percent increase in its budget under President Clinton's proposed plan. For that reason, as much as any other, the spending plan that Congress is now writing for the fiscal year that begins October 1 shapes up as one of the best research-fundin

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Question of the day: Why is basic research, particularly biomedical research, like highways and bridges? Answer: Because Congress loves them both, especially in this election year.

Varmus
'MIRACULOUS': NIH, under the direction of Harold Varmus, would get an 8.4 percent increase in its budget under President Clinton's proposed plan.
For that reason, as much as any other, the spending plan that Congress is now writing for the fiscal year that begins October 1 shapes up as one of the best research-funding budgets in decades, and possibly the best ever.

President Bill Clinton set the tone last month, when he sent Congress a fiscal year (FY) 1999 budget that proposed a $2 billion increase, or 3 percent, in overall federal R&D spending. Clinton plans 8 percent jumps for both defense and civilian basic research, a 6 percent increase for civilian R&D, and a 0.3 percent trim in defense R&D that would raise ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bruce Agnew

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo